ANCA-associated vasculitis
Showing 1 - 25 of >10,000
ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis Trial (Pioglitazone (ACTOS®),
Not yet recruiting
- ANCA Associated Vasculitis
- +2 more
- Pioglitazone (ACTOS®)
- Placebo of Pioglitazone
- (no location specified)
Jul 7, 2023
Antineutrophil Cytoplasmic Antibody-associated Vasculitis Trial (Avacopan, Placebo, Standard of Care)
Not yet recruiting
- Antineutrophil Cytoplasmic Antibody-associated Vasculitis
- Avacopan
- +2 more
- (no location specified)
Oct 6, 2023
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
ANCA Associated Vasculitis Trial in Beijing (Telitacicept, Placebo of Telitacicept)
Recruiting
- ANCA Associated Vasculitis
- Telitacicept
- Placebo of Telitacicept
-
Beijing, ChinaPeking Union Medical College Hospital
Jul 19, 2023
Subclinical Cytomegalovirus Reactivation in Acute
Recruiting
- ANCA Associated Vasculitis
-
Birmingham, West Midlands, United KingdomUniversity Hospitals Birmingham
Jan 15, 2023
ANCA Associated Vasculitis Trial in Bordeaux (blood sample, urine sample)
Recruiting
- ANCA Associated Vasculitis
- blood sample
- urine sample
-
Bordeaux, FranceCHU de Bordeaux - Service d'Immunologie et Immunogénétique
Dec 13, 2022
Avacostar - (PASS)
Not yet recruiting
- ANCA-associated Vasculitis
- (no location specified)
Jun 12, 2023
ANCA-associated Vasculitis Trial in Brest (Blood samples (80 mL), Fecal samples, Urinary sample (20-40 mL))
Recruiting
- ANCA-associated Vasculitis
- Blood samples (80 mL)
- +3 more
-
Brest, FranceCHRU de Brest - Service de rhumatologie
Oct 28, 2022
ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)
Recruiting
- ANCA Associated Vasculitis
- +2 more
-
Edinburgh, United KingdomCentre for Cardiovascular Science, Queen's Medical Research Inst
Jan 26, 2023
Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis Trial in Boston, Rochester, Philadelphia
Not yet recruiting
- Granulomatosis With Polyangiitis
- +2 more
-
Boston, Massachusetts
- +2 more
Dec 29, 2022
Pediatric ANCA Associated-vasculitis
Recruiting
- ANCA-Associated Vasculitis
-
Strasbourg, FranceService de Pédiatrie 1 - CHU de Strasbourg - France
May 19, 2022
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared
Recruiting
- ANCA-associated Vasculitis
- +2 more
-
Calgary, Alberta, Canada
- +8 more
Jan 27, 2023
ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)
Recruiting
- ANCA Associated Vasculitis
- Rituximab
- +3 more
-
Leiden, Zuid-Holland, Netherlands
- +3 more
May 16, 2022
ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis Trial in Toronto (vitamin D)
Active, not recruiting
- ANCA-associated Vasculitis
- +3 more
- vitamin D
-
Toronto, CanadaMount Sinai Hospital, Vasculitis clinic
Feb 15, 2022
Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,
Not yet recruiting
- Idiopathic Inflammatory Myopathies
- +3 more
- KYV-101
- +2 more
- (no location specified)
Nov 21, 2023
Kidney Failure, Acute Trial in Marseille (Apheresis technics)
Recruiting
- Kidney Failure, Acute
- Apheresis technics
-
Marseille, FranceAssisatance Publique Hôpitaux de Marseille
Mar 22, 2022
Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Recruiting
- Takayasu's Arteritis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
ANCA Associated Vasculitis Trial in Changsha (No Intervention)
Recruiting
- ANCA Associated Vasculitis
- No Intervention
-
Changsha, Hunan, ChinaXiangya hospital
Apr 6, 2022
Invasive Pneumococcal Infection Trial in Paris (PCV13, PPV23, Rituximab)
Completed
- Invasive Pneumococcal Infection
- PCV13
- +2 more
-
Paris, FrancePôle de Médecine Interne, Centre de référence " Maladies systémi
Jun 7, 2022
Occupational and Environmental Origins of ANCA Vasculitis:
Not yet recruiting
- ANCA Associated Vasculitis
- +2 more
-
Bordeaux, France
- +10 more
Jun 9, 2022
ANCA Associated Vasculitis, Granulomatosis With Polyangiitis Trial in United Kingdom (Belimumab, Rituximab, Prednisolone)
Active, not recruiting
- ANCA Associated Vasculitis
- Granulomatosis With Polyangiitis
- Belimumab
- +2 more
-
Cambridge, United Kingdom
- +5 more
Feb 21, 2022
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing
Recruiting
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- ANCA-Associated Glomerulonephritis
-
Chongqing, Chongqing, ChinaChildren's Hospital of Chongqing Medical University
Jul 23, 2023
ANCA Associated Vasculitis Trial in Chapel Hill (ENUMERATION OF CD5+ B Cells)
Recruiting
- ANCA Associated Vasculitis
- ENUMERATION OF CD5+ B Cells
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Nov 29, 2021
Co-occurrence of ANCA Vasculitis and Sjögren Syndrome
Completed
- ANCA Associated Vasculitis
- Sjogren's Syndrome
-
Montpellier, FranceUhmontpellier
Sep 6, 2021
ANCA Associated Vasculitis, Maintenance Therapy Trial in China (Leflunomide, Azathioprine Tablets)
Recruiting
- ANCA Associated Vasculitis
- Maintenance Therapy
- Leflunomide
- Azathioprine Tablets
-
Hefei, Anhui, China
- +3 more
Nov 26, 2021